Find a Clinical Trial

Showing 1 - 6 out of 6

Gemini 1

A Phase 3, randomized, double-blind efficacy and safety study comparing SAR442168 to teriflunomide (Aubagio^®) in participants with relapsing forms of multiple sclerosis

Multiple sclerosis

All genders

18-55

Recruiting now

Department of Neurology

Tufts Medical Center

Learn more

Hercules

A Phase 3, randomized, double-blind, efficacy and safety study comparing SAR442168 to placebo in participants with nonrelapsing secondary progressive multiple sclerosis

Multiple sclerosis

All genders

18-60

Recruiting now

Department of Neurology

Tufts Medical Center

Learn more

PERSEUS

A Phase 3, Randomized, Double-Blind, Efficacy and Safety Study Comparing SAR442168 to Placebo in Participants with Primary Progressive Multiple Sclerosis

Multiple sclerosis

All genders

18-55

Recruiting now

Department of Neurology

Tufts Medical Center

Learn more

Period Kits

Development and Evaluation of “Period Kits” for Adolescents with Intellectual and Cognitive Disabilities

Autism, Menstruation

All genders

0-17

Recruiting now

Department of Obstetrics + Gynecology

Tufts Medical Center

Learn more

Remodel-2

Efficacy and safety of remibrutinib compared to teriflunomide in participants with relapsing multiple sclerosis

Multiple sclerosis

All genders

18-55

Recruiting now

Department of Neurology

Tufts Medical Center

Learn more

Adolescent SQ injection video validation

Validation of a video teaching tool for Adolescent Self Administration of Subcutaneous depot-medroxyprogesterone

Pain

All genders

0-19

Recruiting now

Department of Obstetrics + Gynecology

Tufts Medical Center

Learn more

Find Care

Services + Treatments

Patients + Visitors

Research + Academics

Clinicians

Find a Clinical Trial

Filter

A Phase 3, randomized, double-blind efficacy and safety study comparing SAR442168 to teriflunomide (Aubagio^®) in participants with relapsing forms of multiple sclerosis

A Phase 3, randomized, double-blind, efficacy and safety study comparing SAR442168 to placebo in participants with nonrelapsing secondary progressive multiple sclerosis

A Phase 3, Randomized, Double-Blind, Efficacy and Safety Study Comparing SAR442168 to Placebo in Participants with Primary Progressive Multiple Sclerosis

Development and Evaluation of “Period Kits” for Adolescents with Intellectual and Cognitive Disabilities

Efficacy and safety of remibrutinib compared to teriflunomide in participants with relapsing multiple sclerosis

Validation of a video teaching tool for Adolescent Self Administration of Subcutaneous depot-medroxyprogesterone

Find Care

Services + Treatments

Patients + Visitors

Research + Academics

Clinicians

Find a Clinical Trial

Filter

A Phase 3, randomized, double-blind efficacy and safety study comparing SAR442168 to teriflunomide (Aubagio®) in participants with relapsing forms of multiple sclerosis

A Phase 3, randomized, double-blind, efficacy and safety study comparing SAR442168 to placebo in participants with nonrelapsing secondary progressive multiple sclerosis

A Phase 3, Randomized, Double-Blind, Efficacy and Safety Study Comparing SAR442168 to Placebo in Participants with Primary Progressive Multiple Sclerosis

Development and Evaluation of “Period Kits” for Adolescents with Intellectual and Cognitive Disabilities

Efficacy and safety of remibrutinib compared to teriflunomide in participants with relapsing multiple sclerosis

Validation of a video teaching tool for Adolescent Self Administration of Subcutaneous depot-medroxyprogesterone

A Phase 3, randomized, double-blind efficacy and safety study comparing SAR442168 to teriflunomide (Aubagio^®) in participants with relapsing forms of multiple sclerosis